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Metabolic Bone Disease and the Hip
Robert Lindsay, MBChB, PhD'

F

racture of the hip is the most serious of the fractures of the
aging population. However, the relationship between osteoporosis and fracture presentation has been questioned. Riggs
and Melton (1) have postulated that the aging bone loss that precedes fracture of the hip is consequent upon the gradual decline
in the supply of 1,25-dihydroxycholecalciferol [l,25-(OH)2D]
probably consequent upon reduction in renal function. This session examined some of these issues about hip fractures including
its epidemiology, its relationship to bone disease and particularly to l,25-(OH)2D supply, as well as current approaches to
treatment of patients with hip fracture from both medical and
surgical viewpoints.

Epidemiology of Hip Fractures and Falls
Cummings and Nevitt (2) reviewed the epidemiology of falls
and hip fractures. It is well known that the risk of hip fracture
increases with age in both males and females, as does the risk of
falls. However, only a small percentage of falls result in hip fracture (~1%).
A variety of factors are thought to influence this relationship,
but the final conclusion seems inescapable. The energy from the
fall that is transmitted to the femoral neck must exceed its
strength, which is closely related to its mineral "density." Thus,
there are larger differences in bone mass between those who
have suffered a hip fracture and those who have fallen but did not
fracture than between the former group and "normals." Presumably, therefore, if bone mass did not fall with age then injury to
the femoral neck would be significantly less likely, although
clearly further study of the relationship is required. The conclusion might be, however, that hip fracture is a phenomenon of
aging, and consequently if everyone were to live long enough all
would fracture a hip.

Noninvasive Measurement of Bone Loss
in the Femoral Neck
Wahner (3) evaluated the techniques for measurement of bone
in the femoral neck. At present dual photon absorptiometry
(DPA) and dual energy x-ray analysis (DEXA), the x-ray equivalent of DPA, are the only available methods. Unlike measurements of the spine, DEXA does not appear, on preliminary data,
to provide significant improvements in precision over DPA, although the shorter scanning time will allow more intensive quality control. Curiously, part of the overlap noted between normals and fracture patients could be attributed to the effect of
variable distance between source and object (ie, the femoral
neck) and not due to true difference in bone mass.
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The Relationship Between the Iliac Crest Bone
Biopsy and Other Skeletal Sites
Since the hip is not an easy site to measure, the question of the
interrelationships between sites was examined (4). Using bone
biopsy as the standard, it was noted that while there were significant relationships between spine and iliac crest cancellous bone
volume, the values obtained in the spine were always lower, with
thinner trabeculae and different spatial configuration. Few data
are'available comparing femoral neck with biopsy, and clearly
further study of this issue is required. Clarification of the relationship between spinal measurements and hip measurements
was not examined but clearly is also an issue; the importance of
disproportionate loss of trabecular bone at each of these sites
was an issue that was raised during the discussion. Wide variability in tumover between sites has been observed in the few
data available. This is clearly important since tumover data from
the standard biopsy site are increasingly being used in deciding
the therapeutic approach to the patient.

Stochastic Models of Femoral Bone Loss
and Hip Fracture Risk
In the modeling approach to the assessment ofrisk,Horsman
and Burkinshaw (5) presented information demonstrating how a
model system might be used to determine the degree ofriskof
fracture of the hip for any individual. It is clear that to allow such
a model to be put into clinical use more detailed information
about the epidemiology of falls and their relationship to fracture
is required. However, predictability is important to the clinician
since many patients will present either at menopause or at the
time of first fracture, usually of distal radius or spine, and treatment should probably be initiated at one of those time markers.

Vitamin D Nutrition and Metabolism in Aging
and Osteoporosis; and Femoral Fracture:
The Role of Vitamin D
The second half of this session examined the potential role of
vitamin D metabolism in the pathogenesis of the disorder. In the
first ofthe two presentations, Clemens (6) reviewed the evidence
for declining plasma levels of l,25-(OH),D with age. In the second. Peacock and Hordon (7) noted the decline in 25-(OH)D
seen most obviously in Great Britain and suggested that insufficiency of this metabolite was a causative factor in bone loss and
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hip fracture. However, both presentations stressed the importance of impaired conversion of 25-(OH)D to its 1-hydroxyIated
metabolite as part of the aging process. This was demonstrated
by two different approaches, but the biological consequences
have yet to be confirmed. Reduced calcium absorption does appear to result in hip fracture. Unlike the case of healthy elderly,
the reduced absorption is not reversed by precursor administration (7).
As was evident from the detailed and wide-ranging discussion, further work is clearly required in this area, particularly in
determining the clinical consequences of these alterations in vitamin D metabolism and subsequently in establishing treatment
protocols to reverse them.

The Orthopedist and Hip Fractures
In the final section ofthis session, attention was tumed toward
treatment aspects. Lane et al (8) emphasized the importance of
early definitive intervention for both intertrochanteric and
femoral neck fractures. Hemiarthroplasty as the initial approach
for patients over age 70 appears to be associated with only 5%
mortality after six months for patients with true femoral neck
fractures. Sliding nail plates remain the treatment of choice for
intertrochanteric fractures.

Medical Management of Osteoporosis of the Hip
Kraenzlin et al (9) presented evidence that sodiumfluorideincreases bone mass in the hip as well as in the spine. Again, however, the mechanical strength of the fluoride bone was questioned in the discussion. The differential response, at least in
terms ofthe magnitude of change, may be due to differences in
remodeling rates at different sites, but more data are required to
substantiate this. No data are available, however, to tell the clinician how best to treat the skeleton of the patient who presents
after surgical intervention for hip fracture.

Final Note
This session of the meeting tended to emphasize the areas in
which there is lack of knowledge, and indeed it is sobering that
in 1988 we still do not understand the important pathogenetic
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factors that lead to fractures of the hip, nor do we understand the
medical interventions that are likely to benefit these patients. At
several times the value of long-term prevention of bone loss with
estrogen was stressed, and indeed this still seems to be all that
can be offered to the aging female population that might be expected to reduce hip fracture frequency. Even there we are faced
with the problem of identification of the high-risk patient, and
further refinement of Horsman and Burkinshaw's (5) model may
be of value. Improvements appear to have been greatest in the
surgical approach to hip fractures, and the reduced mortality for
femoral neck fractures is an important issue. Clearly further
evaluation of the type I and type II hypothesis for osteoporosis
requires more detailed investigation, particularly since data
obtained in one country may not correlate with the findings
in another.
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